Occurrence of ovulation after intracerebroventricular infusion of substance P in 6-OHDA pretreated female rats

• Autorzy: Aslanowicz-Antkowiak K , Traczyk W.Z.
• Języki publikacji: EN

Abstrakty

EN

Substance P (SP) infused into the third cerebral ventricle blocks spontaneous ovulation in female rats, probably through catecholaminergic neurons. The studies presented in this paper were undertaken to investigate whether SP exerts its suppressing effect on ovulation in 6-hydroxydopamine (6-OHDA) pretreated female rats. After 8-12 days following 6-OHDA pretreatment female rats were infused, on the day of proestrus, with vehicle and all animals were found to ovulate or with a solution containing 5 nmol of SP and 89% of female rats were then found to ovulate. In the group pretreated with vehicle and subsequently infused with SP, ovulation was found to occurr only in 25% of animals. The obtained results indicate that spontaneous ovulation in 6-OHDA-pretreated female rats cannot be blocked by i. c. v. administration of SP, and it may be concluded that SP exerts its suppressing effect through the monoaminergic neurons.

Słowa kluczowe

EN

hydroxydopamine; ovulation; intracerebroventricular infusion; rat; substance P

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 1992
• Tom: 43
• Numer: 1
• Opis fizyczny: p.89-95

Twórcy

autor

Aslanowicz-Antkowiak K

• Medical University of Lodz, ul.Lindleya 3, 90-131 Lodz, Poland

autor

Traczyk W.Z.

Bibliografia

• 1. Kacprzak E. Traczyk WZ. Effect on the estrous cycle of female rats of implantation of Substance P fragment SP₆₋₁₁ into the diencephalon. In: Ajmone Marsan C. Traczyk WZ, eds. Neuropeptides and Neural Transmission. New York: Raven Press, 1980: pp. 141-151.
• 2. Jakubowska-Naziembło B. Włodzimierska В. Traczyk WZ. Effect of intracerebroventricular administration of Substance P and its hexapeptide fragment on the estrus cycle in female rats. Acta Physiol Pol 1980; 31:637-645.
• 3. Potargowicz E. Jakubowska-Naziembło В. Suppression of ovulation by Substance P administered into the third cerebral ventricle of female rats. Zwierzęta Laboratoryjne 1987; 24:47-58.
• 4. Antonowicz U. Jakubowska-Naziembło В. Cannon D. Powell D. Immunoreactive Substance P content in median eminence and pituitary gland during oestrus, dioestrus and after anterior hypothalamic deafferentation. Endokrinologie 1982; 79:25-34.
• 5. Jakubowska-Naziembło В. Antonowicz U. Cannon D. Powell D. Rohde W. Immunoreactive Substance P and LH-RH content in median eminence and pituitary gland during proestrus, oestrus, lactation and after anterior hypothalamic deafferentation. Exp. Clin Endocrinol 1985; 85:155-166.
• 6. Asłanowicz-Antkowiak K. Occurrence of pregnancy despite spontaneous ovulation suppression by intracerebroventricular infusion of Substance P in rats. Endocrinologia Experimental 1987; 21:291-298.
• 7. Gnodde HP, Schuiling GA. Involvement of catecholaminergic and cholinergic mechanisms in the pulsatile release of LH in the long-term ovariectomized rat. Neuroendocrinology 1976; 20:212-223.
• 8. Tima L. Flerko B. Ovulation induced by norepinephrine in rats made anovulatory by various experimental procedures. Neuroendocrinology 1974; 15:346-354.
• 9. Potargowicz E. Traczyk WZ. Suppression of noradrenaline-induced ovulation by administration of Substance P into the third cerebral ventricle in pseudo-pregnant rats. In: Henry JL, Couture R. eds. Substance P and Neurokinins. New York: Springer Verlag, 1988: 321-323.
• 10. Asłanowicz-Antkowiak K. Lack of suppressing effect of intracerebroventricular infusion of Substance P on the occurrence of ovulation in 6-OHDA pretreated rats. Abstracts of lectures and communications of the XVII Congress of the Polish Physiological Society. Acta Physiol. Pol. Supplement 30, 1987; 38:3.
• 11. König JFR, Klippel RA. The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams and Wilkins, 1963.
• 12. Wald A. Wolfowitz J. According to: Blalock HM Jr. Social Statistics. New York-Toronto-London: McGraw-Hill Book Company Inc. 1960: pp. 193-197 and 443.
• 13. Kerdelhue B. Valens M. Langlois Y. Stimulation de la secretion de la LH et de la FSH hypophysaire apres immunoneutralisation de la Substance P endogene, chez la ratte cyclique. CR Acad Sci Paris D 1978; 286:977-979.
• 14. Ljungdahl A. Hokfelt T. Wilsson G. Goldstein M. Distribution of Substance P-like immunoreactivity in the central nervous system of the rat. II Light microscopic localization in relation to catecholamine-containing neurons. Neuroscience 1978; 3:945-976.
• 15. Kalra PS, Kalra SP, Krulich L, Fawcett CP, McCann SM. Involvement of norepinephrine rise in transmission of the stimulatory influence of progesterone on gonadotropin release. Endocrinology 1972; 90:1168-1176.
• 16. Kalra SP, McCann SM. Effects of drugs modifying catecholamine synthesis on LH release induced by preoptic stimulation in the rat. Endocrinology 1973; 93:356-362.
• 17. Sawyer CH, Hilliard J. Kanematsu S. Scaramuzzi R. Blake CA. Effects of intraventricular infusions of norepinephrine and dopamine on LH release and ovulation in the rabbit. Neuroendocrinology 1974; 15:328-337.
• 18. Krieg RJ, Sawyer CH. Effects of intraventricular catecholamines on luteinizing hormone release in ovariectomized-steroid-primed rats. Endocrinology 1976; 99:411-419.
• 19. Uretsky NJ, Iversen LL. Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature 1969; 221:557-559.
• 20. Ungerstedt U. Histochemical studies on the effect of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain. In: Malmfors T. Thoenen H., eds. 6-hydroxydopamine and catecholamine neurons. Amsterdam: North-Holland Publ. 1971: pp. 101-127.
• 21. Commins DL, Shaughnessy RA, Axt KJ, Vosmer G. Seiden LS. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions. J Neural Transm 1989; 77:197-210.
• 22. Rivet JM, Stinus L, Le Moal M. Mormede P. 6-Hydroxydopamine lesion of ventral tegmental area dopaminergic cell bodies does not impair neuroendocrine responses to environmental stimuli. J Neuroendocrinol 1990; 2:733-736.
• 23. Nicholson G. Greeley G. Humm J. Youngblood W. Kizer JS. Lack of effect of noradrenergic denervation of the hypothalamus and medial preoptic area on the feedback regulation of gonadotropin secretion and the estrous cycle of the rat. Endocrinology 1978; 103:559-566.
• 24. Haneke JL. Wuttke W. Effects of chemical lesion of the ventral noradrenergic bundle or of the medial preoptic area on preovulatory LH release in rats. Exp Brain Res 1979; 35:127-134.
• 25. Martinovic JV, McCann SM. Effect of lesions in the ventral noradrenergic tract produced by microinjection of 6-hydroxydopamine on gonadotropin release in the rat. Endocrinology 1977; 100:1206-1213.
• 26. Bacha JC, Donoso AO. Enhanced luteinizing hormone release after noradrenaline treatment in 6-hydroxydopamine-treated rats. J Endocrinol 1,974; 62:169-170.
• 27. Ramirez VD, Feder HH, Sawyer CH. The role of brain catecholamines in the regulation of LH secretion: a critical inquiry. In: Martini L. Ganong WF, eds. Frontiers in Neuroendocrinology. New York: Raven Press, 1984: pp. 27-84.
• 28. Picanco-Diniz DLW, Valenca MM, Franci CR, Antunes-Rodrigues J. Role of Substance P in the medial preoptic area in the regulation of gonadotropin and prolactin secretion in normal or orcjiidectomized rats. Neuroendocrinology 1990; 51:675-682.